Outcomes and prognostic factors of conformal radiotherapy versus intensity-modulated radiotherapy for nasopharyngeal carcinoma

Clinical and Translational Oncology

Volumn 14, Issue 10, 2012, Pages 783-790

  Kuang, Wei Lu ^a   Zhou, Qin ^a   Shen, Liang Fang ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Conformal radiotherapy; Intensity modulated radiotherapy; Nasopharyngeal carcinoma

Indexed keywords

PLATINUM COMPLEX;

ACUTE TOXICITY; ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; COMPARATIVE STUDY; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISTANT METASTASIS FREE SURVIVAL; FEMALE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LOCAL REGIONAL CONTROL; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTIVARIATE ANALYSIS; NASOPHARYNX CARCINOMA; OVERALL SURVIVAL; PREDICTIVE VALUE; PROGNOSIS; RADIATION DERMATITIS; RETROSPECTIVE STUDY; TREATMENT OUTCOME; XEROSTOMIA;

ADULT; AGED; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; PROGNOSIS; RADIOTHERAPY, CONFORMAL; RADIOTHERAPY, INTENSITY-MODULATED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84871294023     PISSN: 1699048X     EISSN: 16993055     Source Type: Journal    
DOI: 10.1007/s12094-012-0864-5     Document Type: Article

References (26)

1. Jia WH, Huang QH, Liao J, Ye W, Shuqart YY, Liu Q et al (2006) Trends in incidence and mortality of nasopharyngeal carcinoma over a 20-25 year period (1978/1983-2002) in Sihui and Cangwu counties in Southern China. BMC Cancer 6:178-186
2. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55(2):74-108
3. Zhang Y, Lin ZA, Pan JJ, Zheng Z, Yang L, Lin SJ et al (2009) Concurrent control study of different radiotherapy for primary nasopharyngeal carcinoma: intensity-modulated radiotherapy versus conventional radiotherapy. Chin J Cancer 28(11):1143-1148
4. Pow EH, Kwong DL, McMillan AS, Wong MC, Sham JS, Leung LH et al (2006) Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial. Int J Radiat Oncol Biol Phys 66(4):981-991
5. Kwong DL, Pow EH, Sham JS, McMillan AS, Leung WK, Chua DT et al (2004) Intensity-modulated radiotherapy for early stage nasopharyngeal carcinoma: a prospective study on disease control and preservation of salivary function. Cancer 101(7):1584-1593
6. Lee N, Xia P, Quivey JM, Sultanem K, Poon L, Akazawa C et al (2002) Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Int J Radiat Oncol Biol Phys 53(1):12-22
7. Butler EB, Teh BS, Grant WH 3rd, Uhl BM, Kuppersmith RB, Chiu JK et al (1999) Smart (simultaneous modulated accelerated radiation therapy) boost: a new accelerated fractionation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy. Int J Radtat Oncol Biol Phys 45(1):21-32
8. Mendenhall WM, Amdur RJ, Palta JR (2006) Intensity-modulated radiotherapy in the standard management of head and neck cancer: promises and pitfalls. J Clin Oncol 24(17):2618-2623
9. Kam MK, Teo PM, Chau RM, Cheung KY, Choi PH, Kwan WH et al (2004) Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience. Int J Radiat Oncol Biol Phys 60(5):1440-1450
10. Wolden SL, Chen WC, Pfister DG, Kraus DH, Berry SL, Zelefsky MJ (2006) Intensity-modulated radiotherapy (IMRT) for nasopharynx cancer: update of the Memorial Sloan-Kettering experience. Int J Radiat Oncol Biol Phys 64(1):57-62
11. Yu KH, Teo PM, Lee WY, Leung SF, Choi PH, Johnson PJ (1994) Patterns of early treatment failure in non-metastatic nasopharyngeal carcinoma: a study based on CT scanning. Clin Oncol (R Coll Radiol) 6(3):167-171
12. Li JX, Lu TX, Huang Y, Han F, Chen CY, Xiao WW (2010) Clinical features of 337 patients with recurrent nasopharyngeal carcinoma. Chin J Cancer 29(1):82-86
13. Baujat B, Audry H, Bourhis J, Chan AT, Onat H, Chua DT et al (2006) Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized trials and 1, 753 patients. Int J Radiat Oncol Biol Phys 64(1):47-56
14. Langendijk JA, Leemans CR, Buter J, Berkhof J, Slotman BJ et al (2004) The additional value of chemotherapy to radiotherapy in locally advanced nasopharyngeal carcinoma: a meta-analysis of the published literature. J Clin Oncol 22(22):4604-4612
15. Huncharek M, Kupelnick B (2002) Combined chemoradiation versus radiation therapy alone in locally advanced nasopharyngeal carcinoma: results of a metaanalysis of 1, 528 patients from six randomized trials. Am J Clin Oncol 25(3):219-223
16. Lee AW, Lau WH, Tung SY, Chua DT, Chappell R, Xu L et al (2005) Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally advanced nasopharyngeal carcinoma: NPC-9901 trial by the Hong Kong Nasopharyngeal Cancer Study Group. J Clin Oncol 23(28):6966-6975
17. Lu X, Guo X, Hong MH, Chen QY, Zeng Q, Xiang YQ (2010) Comparison of the short-term efficacy of two inductive chemotherapy regimens for locally advanced nasopharyngeal carcinoma: docetaxal plus carboplatin versus 5-fluorouracil plus carboplatin. Chin J Cancer 29(2):140-144
18. Xie FY, Qi SN, Hu WH, Zou GR, Peng M, Li JS (2007) Comparison of efficacy of docetaxel combined cisplatin (TP regimen) and cisplatin combined 5-fluorouracil (PF regimen) on locally advanced nasopharyngeal carcinoma. Ai Zheng 26(8):880-884
19. Huang PY, Mai HQ, Luo DH, Qiu F, Li NW, Xiang YQ et al (2009) Inductionconcurrent chemoradiotherapy versus induction chemotherapy and radiotherapy for locoregionally advanced nasopharyngeal carcinoma. Ai Zheng 28(10):1033-1042
20. Hui EP, Ma BB, Leung SF, King AD, Mo F, Kam MK et al (2009) Randomized phase II trial of concurrent cisplatin-radiotherapy with or without neoadjuvant docetaxel and cisplatin in advanced nasopharyngeal carcinoma. J Clin Oncol 27:242-249
21. Chi KH, Chang YC, Guo WY, Leung MJ, Shiau CY, Chen SY et al (2002) A phase III study of adjuvant chemotherapy in advanced nasopharyngeal carcinoma patients. Int J Radiat Oncol Biol Phys 52(5):1238-1244
22. Liu MZ, Tang LL, Zong JF, Huang Y, Sun Y, Mao YP et al (2008) Evaluation of sixth edition of AJCC staging system for nasopharyngeal carcinoma and proposed improvement. Int J Radiat Oncol Biol Phys 70(4):1115-1123
23. Mao YP, Xie FY, Liu LZ, Sun Y, Li L, Tang LL et al (2009) Re-evaluation of 6th edition of AJCC staging system for nasopharyngeal carcinoma and proposed improvement based on magnetic resonance imaging. Int J Radiat Oncol Biol Phys 73(5):1326-1334
24. Han L, Lin SJ, Pan JJ, Chen CB, Zhang Y, Zhang XC et al (2010) Prognostic factors of 305 nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy. Chin J Cancer 29(2):145-150
25. Lin S, Lu JJ, Han L, Chen Q, Pan J (2010) Sequential chemotherapy and intensity-modulated radiotherapy in the management of locoregionally advanced nasopharyngeal carcinoma: experience of 370 consecutive cases. BMC Cancer 10:39
26. Zhang Y, Lin J, Zhou W, Tang J, Liao Y (2009) Dosimetric verification and clinical efficacy of intensity modulated radiotherapy in nasopharyngeal carcinoma. Zhong Nan Da Xue Xue Bao Yi Xue Ban 34(9):879-885